Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company, is catching the attention of investors with its promising pipeline in gene and cell therapies targeted at life-threatening diseases. With a..

Abeona Therapeutics Inc. (NASDAQ: ABEO), a promising player in the biotechnology sector, is capturing investor interest with a notable potential upside of 232.70%. Specializing in the development of cutting-edge gene..

Abeona Therapeutics Inc. (ABEO), a promising player in the biotechnology sector, is gaining traction among investors due to its innovative approach in developing gene and cell therapies aimed at life-threatening..